Two patients harboured more than one pathogenic variant: one with diffuse astrocytoma was found to have concurrent TP53 exon 1 deletion and NF1 nonsense mutation, and a Sertoli−Leydig cell tumour (SLCT) patient harboured both DICER1 frameshift and nonsense FH mutations. Here, TP53 is linked to diffuse astrocytoma.